These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 31681337)

  • 21. Epigenetic control of thymic Treg-cell development.
    Kitagawa Y; Ohkura N; Sakaguchi S
    Eur J Immunol; 2015 Jan; 45(1):11-6. PubMed ID: 25348287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging Functions of Regulatory T Cells in Tissue Homeostasis.
    Sharma A; Rudra D
    Front Immunol; 2018; 9():883. PubMed ID: 29887862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamics of peripheral tolerance and immune regulation mediated by Treg.
    Sakaguchi S; Wing K; Yamaguchi T
    Eur J Immunol; 2009 Sep; 39(9):2331-6. PubMed ID: 19662638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal acetylation of FOXP3 regulated by SIRT-1 induces Treg functional deficiency in patients with abdominal aortic aneurysms.
    Jiang H; Xin S; Yan Y; Lun Y; Yang X; Zhang J
    Atherosclerosis; 2018 Apr; 271():182-192. PubMed ID: 29524861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulatory T Cells: the Many Faces of Foxp3.
    Georgiev P; Charbonnier LM; Chatila TA
    J Clin Immunol; 2019 Oct; 39(7):623-640. PubMed ID: 31478130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histone/protein deacetylase inhibitor therapy for enhancement of Foxp3+ T-regulatory cell function posttransplantation.
    Wang L; Beier UH; Akimova T; Dahiya S; Han R; Samanta A; Levine MH; Hancock WW
    Am J Transplant; 2018 Jul; 18(7):1596-1603. PubMed ID: 29603600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving regulatory T cell-based therapy: insights into post-translational modification regulation.
    Wang A; Wang Y; Liang R; Li B; Pan F
    J Genet Genomics; 2024 Sep; ():. PubMed ID: 39357622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The lineage stability and suppressive program of regulatory T cells require protein O-GlcNAcylation.
    Liu B; Salgado OC; Singh S; Hippen KL; Maynard JC; Burlingame AL; Ball LE; Blazar BR; Farrar MA; Hogquist KA; Ruan HB
    Nat Commun; 2019 Jan; 10(1):354. PubMed ID: 30664665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ubiquitin-dependent regulation of Foxp3 and Treg function.
    Barbi J; Pardoll DM; Pan F
    Immunol Rev; 2015 Jul; 266(1):27-45. PubMed ID: 26085205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells.
    Cook L; Stahl M; Han X; Nazli A; MacDonald KN; Wong MQ; Tsai K; Dizzell S; Jacobson K; Bressler B; Kaushic C; Vallance BA; Steiner TS; Levings MK
    Gastroenterology; 2019 Dec; 157(6):1584-1598. PubMed ID: 31513797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanisms underlying the regulation and functional plasticity of FOXP3(+) regulatory T cells.
    Gao Y; Lin F; Su J; Gao Z; Li Y; Yang J; Deng Z; Liu B; Tsun A; Li B
    Genes Immun; 2012 Jan; 13(1):1-13. PubMed ID: 22048454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional regulation of Foxp3 in regulatory T cells.
    Haiqi H; Yong Z; Yi L
    Immunobiology; 2011 Jun; 216(6):678-85. PubMed ID: 21122941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting post-translational modifications of Foxp3: a new paradigm for regulatory T cell-specific therapy.
    Riaz F; Huang Z; Pan F
    Front Immunol; 2023; 14():1280741. PubMed ID: 37936703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dendritic cells support homeostatic expansion of Foxp3+ regulatory T cells in Foxp3.LuciDTR mice.
    Suffner J; Hochweller K; Kühnle MC; Li X; Kroczek RA; Garbi N; Hämmerling GJ
    J Immunol; 2010 Feb; 184(4):1810-20. PubMed ID: 20083650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of Treg Functions by the Ubiquitin Pathway.
    Montauti E; Fang D
    Adv Exp Med Biol; 2021; 1278():47-62. PubMed ID: 33523442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel upstream enhancer of FOXP3, sensitive to methylation-induced silencing, exhibits dysregulated methylation in rheumatoid arthritis Treg cells.
    Kennedy A; Schmidt EM; Cribbs AP; Penn H; Amjadi P; Syed K; Read JE; Green P; Gregory B; Brennan FM
    Eur J Immunol; 2014 Oct; 44(10):2968-78. PubMed ID: 25042153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Foxp3 is critical for human natural CD4+CD25+ regulatory T cells to suppress alloimmune response.
    Sun L; Wu J; Yi S
    Transpl Immunol; 2012 Mar; 26(2-3):71-80. PubMed ID: 22079196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and maintenance of regulatory T cells.
    Ohkura N; Kitagawa Y; Sakaguchi S
    Immunity; 2013 Mar; 38(3):414-23. PubMed ID: 23521883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homeobox protein Hhex negatively regulates Treg cells by inhibiting Foxp3 expression and function.
    Jang SW; Hwang SS; Kim HS; Kim MK; Lee WH; Hwang SU; Gwak J; Yew SK; Flavell RA; Lee GR
    Proc Natl Acad Sci U S A; 2019 Dec; 116(51):25790-25799. PubMed ID: 31792183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetical Targeting of the FOXP3 Gene by S-Adenosylmethionine Diminishes the Suppressive Capacity of Regulatory T Cells Ex Vivo and Alters the Expression Profiles.
    Sahin E; Sahin M
    J Immunother; 2019 Jan; 42(1):11-22. PubMed ID: 30407230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.